Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2014 Dec 2;62(5):759–765. doi: 10.1002/pbc.25340

Table IV.

Characteristics of patients with and without CDKN2A and/or TP53 alterations

CDKN2A Deleted
N=12
CDKN2A Normal
N = 95
P-value TP53 Mutation
N=8
TP53 Normal
N=85
P-value
Demographics N % N % N % N %
Age 0.22 0.067
<=9 3 25% 33 35% 0 0% 31 36%
10-17 7 58% 58 61% 7 88% 50 59%
18<= 2 17% 4 4% 1 13% 4 5%
Sex 0.76 0.72
Male 6 50% 53 56% 4 50% 50 59%
Female 6 50% 42 44% 4 50% 35 41%
Race 0.75 0.013
Caucasian 11 92% 85 89% 6 75% 81 95%
African American 0 0% 2 2% 1 13% 0 0%
Asian 0 0% 1 1% 1 13% 0 0%
Other 0 0% 2 2% 0 0% 2 2%
Missing 1 8% 5 5% 0 0% 2 2%
Primary Tumor Site 0.2 0.4
Appendicular 4 33% 38 40% 2 25% 31 36%
Thoracic 0 0% 15 16% 1 13% 13 15%
Pelvic 4 33% 15 16% 2 25% 1 1%
Other Axial 2 17% 6 6% 0 0% 9 11%
Extraosseous 2 17% 21 22% 3 38% 15 18%